Where I see patients (1)
Selected research
-
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
Blood cancer journal
-
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.
Clinical lymphoma, myeloma & leukemia
-
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Blood advances
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421